U
Navidea Biopharmaceuticals, Inc. NAVB
$0.0001 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2023 06/30/2023 03/31/2023 12/31/2022 09/30/2022
Net Income 106.99% 61.62% -16.30% -29.38% -40.77%
Total Depreciation and Amortization -10.47% 25.92% 22.38% 24.55% 21.58%
Total Amortization of Deferred Charges 119.15% 520.64% -- -- --
Total Other Non-Cash Items -193.30% -172.70% -173.84% 57.42% 125.70%
Change in Net Operating Assets -103.06% 115.26% 481.91% 440.32% 1,079.50%
Cash from Operations 105.77% 85.98% 16.05% 12.05% 7.61%
Capital Expenditure 77.63% 58.51% 46.28% -150.00% -146.35%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 52.51% 42.17% 12.01% -7.56% -15.28%
Cash from Investing 56.73% 44.74% 18.05% -18.49% -26.38%
Total Debt Issued -88.00% -13.33% -- -- --
Total Debt Repaid -36.04% -36.04% 40.97% -5.37% -27.98%
Issuance of Common Stock 29,163.64% 29,163.64% -100.00% -100.00% -91.88%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -82.18% 229.44% 36.94% -51.33% -56.86%
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 90.83% -7,112.33% -1,898.03% -1,347.14% -1,291.04%
Cash from Financing -83.35% 137.59% 91.52% -41.02% -48.53%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 159.92% 185.70% 81.19% -243.23% -174.58%
Weiss Ratings